Together with the partnership ‘Fostering a European Research Area for Health Research’ (ERA4Health), KCE Trials is happy to announce the opening of the “Trials4Health 2026” call on 6 November, 2025.
This call provides funding for multi-country, comparative effectiveness or drug repurposing Investigator-Initiated Clinical Studies (IICS) in Cardiovascular, Autoimmune and Metabolic diseases. Deadline for submission is 27 January, 2026.
A webinar Info Session will be held on November 13th, from 14:30 to 16:30. for researchers interested in this call (no registration, connection link is available on ERA4Health News).
More information on the ERA4Health partnership, the Trials4Health 2026 call (scope, time table, info session, etc.), and the participating countries/regions and respective funding organisations can be found on the ERA4Health website: https://era4health.eu/calls/trials4health2026.php.
Specific information for interested applicants in Belgium is available on KCE Trials website, section open calls: https://kce.fgov.be/en/kce-trials/calls/open-calls/2026-trials4health-investigator-initiated-call-era4health-partnership
Through this new funding opportunity, KCE Trials aims to strengthen Belgium’s role in international clinical research by enabling local researchers to join or lead ambitious studies.
Interested researchers are encouraged to contact KCE Trials as soon as possible, since some preparatory actions from sponsors are required before 30 November to secure EU funding.
